Social contract theory and just decision making: Lessons from genetic testing for the BRCA mutations
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jonathan Jenkins Ichikawa
Jack Alan Reynolds
Learn more about PhilPapers
Kennedy Institute of Ethics Journal 14 (2):115-142 (2004)
: Decisions about funding health services are crucial to controlling costs in health care insurance plans, yet they encounter serious challenges from intellectual property protection—e.g., patents—of health care services. Using Myriad Genetics' commercial genetic susceptibility test for hereditary breast cancer (BRCA testing) in the context of the Canadian health insurance system as a case study, this paper applies concepts from social contract theory to help develop more just and rational approaches to health care decision making. Specifically, Daniels's and Sabin's "accountability for reasonableness" is compared to broader notions of public consultation, demonstrating that expert assessments in specific decisions must be transparent and accountable and supplemented by public consultation
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Lindsay M. Sabik & Reidar K. Lie (2008). Principles Versus Procedures in Making Health Care Coverage Decisions: Addressing Inevitable Conflicts. Theoretical Medicine and Bioethics 29 (2):73-85.
Bryn Williams-Jones & Vural Ozdemir (2008). Challenges for Corporate Ethics in Marketing Genetic Tests. Journal of Business Ethics 77 (1):33 - 44.
Bryn Williams-Jones & Vural Ozdemir (2007). Challenges for Corporate Ethics in Marketing Genetic Tests. Journal of Business Ethics 77 (1):33-44.
Similar books and articles
Friedrich Heubel (2000). Patients or Customers: Ethical Limits of Market Economy in Health Care. Journal of Medicine and Philosophy 25 (2):240 – 253.
V. Launis (2000). The Use of Genetic Test Information in Insurance: The Argument From Indistinguishability Reconsidered. Science and Engineering Ethics 6 (3):299-310.
Lorian E. Hardcastle, Katherine L. Record, Peter D. Jacobson & Lawrence O. Gostin (2011). Improving the Population's Health: The Affordable Care Act and the Importance of Integration. Journal of Law, Medicine & Ethics 39 (3):317-327.
Rogeer Hoedemaekers & Wim Dekkers (2003). Key Concepts in Health Care Priority Setting. Health Care Analysis 11 (4):309-323.
Michael Parker (2001). Genetics and the Interpersonal Elaboration of Ethics. Theoretical Medicine and Bioethics 22 (5):451-459.
Rogeer Hoedemaekers & Wija Oortwijn (2003). Problematic Notions in Dutch Health Care Package Decisions. Health Care Analysis 11 (4):287-294.
Felix Thiele (2003). Genetic Tests in the Insurance System: Criteria for a Moral Evaluation. Poiesis and Praxis 1 (3):185-195.
Claudia Wild (2008). Polymorphism-Screening: Genetic Testing for Predisposition—Guidance for Technology Assessment. [REVIEW] Poiesis and Praxis 5 (1):1-14.
Gretchen B. Chapman & Frank A. Sonnenberg (eds.) (2000). Decision Making in Health Care: Theory, Psychology, and Applications. Cambridge University Press.
Ellen Matloff & Arthur Caplan (2008). Direct to Confusion: Lessons Learned From Marketing Brca Testing. American Journal of Bioethics 8 (6):5 – 8.
Added to index2009-01-28
Total downloads52 ( #91,877 of 1,941,073 )
Recent downloads (6 months)3 ( #272,622 of 1,941,073 )
How can I increase my downloads?